Inventor · disambiguated record
Amy Beth Holt
Also filed as: HOLT AMY · HOLT Amy Beth
15 granted patents·10 pending applications·215 citations·filing 2002–2022
92Inventor score
Top patents by PatentIndex Score
25 records- 0198US9839655B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2016·Granted Dec 12, 2017·52 cites·10 claims
- 0296US10046015B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2016·Granted Aug 14, 2018·41 cites·16 claims
- 0396US9987311B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2016·Granted Jun 5, 2018·57 cites·23 claims
- 0495US9974815B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2017·Granted May 22, 2018·48 cites·10 claims
- 0593US10610550B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2019·Granted Apr 7, 2020·4 cites·17 claims
- 0690US11058732B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2019·Granted Jul 13, 2021·2 cites·12 claims
- 0790US10357520B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2017·Granted Jul 23, 2019·3 cites·18 claims
- 0878US11419931B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2020·Granted Aug 23, 2022·1 cites·20 claims
- 0976US10471108B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2018·Granted Nov 12, 2019·1 cites·20 claims
- 1076US2022031766A1Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2021·Application pending·0 cites
- 1169US2020171098A1Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2019·Application pending·0 cites
- 1268US2023158083A1Compositions comprising bacterial strains4D PHARMA RES LIMITED·Filed 2022·Application pending·0 cites
- 1366US11419902B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2020·Granted Aug 23, 2022·0 cites·14 claims
- 1466US2020000858A1Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2019·Application pending·0 cites
- 1565US6858773B2Transgenic mice comprising transcription control elements associated with mouse eosinophil peroxidase expressionXENOGEN CORP·Filed 2002·Granted Feb 22, 2005·6 cites·15 claims
- 1664US2019175666A1Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2019·Application pending·0 cites
- 1764US2022257745A1Compositions comprising of bacterial strains4D PHARMA RES LTD·Filed 2022·Application pending·0 cites
- 1862US10391128B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2016·Granted Aug 27, 2019·0 cites·12 claims
- 1961US2021069258A1Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2020·Application pending·0 cites
- 2059US10744166B2Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2018·Granted Aug 18, 2020·0 cites·17 claims
- 2155US10745453B2Compositions and methods for enhancing visual functionUNIV CALIFORNIA·Filed 2019·Granted Aug 18, 2020·0 cites·26 claims
- 2253US7115793B2Isolation and identification of transcription control elements associated with mouse eosinophil peroxidase expressionXENOGEN CORP·Filed 2004·Granted Oct 3, 2006·0 cites·6 claims
- 2350US2020339641A1Compositions and methods for enhancing visual functionUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 2448US2021393773A1Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2021·Application pending·0 cites
- 2548US2021330786A1Compositions comprising bacterial strains4D PHARMA RES LTD·Filed 2021·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Amy Beth Holt files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →